在阿尔茨海默病中,大脑体积和抑郁症之间的关联:神经成像洞察力
Chao Tang1, Jiaxin Yang1, Xiaoyang Lei1
1Department of Neurology, Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou Province, China.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|January 29, 2026
概括
抑郁症在阿尔茨海默病 (AD) 中很常见. 海马缩 (hippocampal atrophy) 是一种大脑异常,显著地将抑郁症与阿尔茨海默病联系在一起,这表明了患者的新治疗目标.
科学领域:
- 神经科学是一个神经科学.
- 老年学是一门学科.
- 精神病学是一个精神病学.
背景情况:
- 阿尔茨海默病 (AD) 经常与抑郁症同时发生,影响认知功能和生活质量.
- 了解这种并发症的神经生物学基础对于开发有效的治疗策略至关重要.
研究的目的:
- 为了研究大脑结构,认知功能和阿尔茨海默病中抑郁症状之间的神经生物学关系.
- 确定海马缩是否调解了抑郁症和AD之间的关联.
主要方法:
- 来自国家阿尔茨海默氏症协调中心的2,722名参与者的分析 (886名阿尔茨海默氏症患者,1,836名对照).
- 神经成像测量大脑体积和老年抑郁症尺度,以评估抑郁症状.
- 多重线性回归和调解分析以检查关联.
主要成果:
- 阿尔茨海默病患者出现抑郁症状的比率更高 (35.3%对14.7%) 和认知障碍 (MMSE 23.1对28.9).
- 发现海马缩显著调解了抑郁症和阿尔茨海默病之间的关系 (间接效应 = -0.107,p < 0.001).
结论:
- 海马缩在抑郁症和阿尔茨海默病之间的联系中起着重要的调解作用.
- 专注于海马体完整性的有针对性的干预措施可能会改善阿兹海默症和抑郁症患者的结果.
相关概念视频
Depression: Overview
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
Brain Imaging
Brain imaging technologies provide critical insights into both the structure and function of the human brain, enabling medical professionals and researchers to diagnose, study, and treat neurological disorders or psychiatric disorders more effectively.
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic Stimulation (TMS).
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic Stimulation (TMS).
Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...


